Hjem › Blærecancer › South Carolina
Blærecancer kliniske forsøg i South Carolina
16 studier for Blærecancer søger deltagere på steder i South Carolina.
Byer i South Carolina
Officiel studietekst (engelsk)
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
- Ralph H Johnson VA Medical Center, Charleston
- Medical University of South Carolina, Charleston
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT07000084Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- AnMed Health Cancer Center, Anderson
- Prisma Health Richland Hospital, Columbia
- McLeod Regional Medical Center, Florence
- og 12 flere
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 40 til 75 · Alle køn · Opdateret 2. okt. 2026 · NCT05334069Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Medical University of South Carolina, Charleston
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT03866382A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
- Grand Strand Medical Center, Myrtle Beach
- AUC Urologists, LLC, Myrtle Beach
- Carolina Urologic Research Center, LLC, Myrtle Beach
- og 2 flere
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07206225ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Carolina Urologic Research Center, Myrtle Beach
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 14. sep. 2026 · NCT05059444A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)
- Carolina Urologic Research Center ( Site 0006), Myrtle Beach
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 11. sep. 2026 · NCT07222488Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
- Charleston Area Medical Center, Charleston
- Carolina Urologic Research Center, LLC, Myrtle Beach
- Lowcountry Urology (Solaris), North Charleston
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 3. sep. 2026 · NCT06567743Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
- Carolina Urologic Research Center, Myrtle Beach
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 24. aug. 2026 · NCT05951179Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer
- START - Carolinas, Myrtle Beach
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 21. aug. 2026 · NCT07480356FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
- Carolina Urologic Research Center, Myrtle Beach
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 20. aug. 2026 · NCT05614739Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
- Medical University of South Carolina, Charleston
- Gibbs Cancer Center-Gaffney, Gaffney
- Self Regional Healthcare, Greenwood
- og 3 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 18. aug. 2026 · NCT07097142LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
- Carolina Urologic Research Center, LLC, Myrtle Beach
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 7. aug. 2026 · NCT04752722An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
- Research Site, Myrtle Beach
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 22. jul. 2026 · NCT07720284cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Medical University of South Carolina, Charleston
- McLeod Health, Florence
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 40 og opefter · Alle køn · Opdateret 20. jan. 2026 · NCT05366881Blue Light Cystoscopy With Cysview® Registry
- Lexington Medical Center, West Columbia
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 18. dec. 2025 · NCT02660645SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Greenville
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 28. okt. 2025 · NCT03452774Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.